• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Changes in malaria incidence after mass drug administration in Nicaragua.

作者信息

Garfield R M, Vermund S H

出版信息

Lancet. 1983 Aug 27;2(8348):500-3. doi: 10.1016/s0140-6736(83)90523-8.

DOI:10.1016/s0140-6736(83)90523-8
PMID:6136655
Abstract

Mass drug administration (MDA) in 1981 reduced the incidence rates of both Plasmodium vivax and P falciparum infection in Nicaragua. Impact on P vivax cases lasted for four months and on P falciparum for seven. Subtherapeutic primaquine doses, the shorter extrinsic cycle of P vivax in the insect vector, and the timing of MDA at a high-transmission period of the year may explain the limited effects of the campaign. Positive results of the anti-malaria campaign included improvements in case-finding and routine surveillance, the apparent prevention of at least 9200 malaria cases, the training of some 70 000 antimalaria volunteers, and the participation of about 70% of the population in anti-malarial activities.

摘要

相似文献

1
Changes in malaria incidence after mass drug administration in Nicaragua.
Lancet. 1983 Aug 27;2(8348):500-3. doi: 10.1016/s0140-6736(83)90523-8.
2
Health education and community participation in mass drug administration for malaria in Nicaragua.尼加拉瓜疟疾群体服药中的健康教育与社区参与
Soc Sci Med. 1986;22(8):869-77. doi: 10.1016/0277-9536(86)90241-8.
3
Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.伯氨喹五日疗法治疗印度间日疟的根治疗效
J Parasitol. 2002 Oct;88(5):1042-4. doi: 10.1645/0022-3395(2002)088[1042:RCEOFD]2.0.CO;2.
4
Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.印度西南部一家三级护理医院对间日疟原虫疟疾成年患者队列采用氯喹-伯氨喹联合疗法的治疗评估
Malar J. 2015 Aug 11;14:310. doi: 10.1186/s12936-015-0824-y.
5
[Does the brief treatment with antimalarials favorably influence drug resistance and recurrences?].抗疟药的短期治疗是否对耐药性和复发有积极影响?
Rev Panam Salud Publica. 2001 Mar;9(3):202-4. doi: 10.1590/s1020-49892001000300015.
6
Therapeutic responses of Plasmodium vivax and P. falciparum to chloroquine, in an area of western India where P. vivax predominates.在印度西部间日疟原虫占主导的地区,间日疟原虫和恶性疟原虫对氯喹的治疗反应。
Ann Trop Med Parasitol. 2008 Sep;102(6):471-80. doi: 10.1179/136485908X311759.
7
Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.在墨西哥南部开展的一项开放性、非随机临床试验中,比较氯喹和伯氨喹联合治疗14天与间歇性单剂量疗法消除间日疟原虫的有效性。
Malar J. 2015 Oct 30;14:426. doi: 10.1186/s12936-015-0938-2.
8
[Treatment of malaria with a combination of 3 drugs on São Luís Island, Maranhão, Brazil].
Rev Bras Malariol Doencas Trop. 1981;33:75-85.
9
UK malaria treatment guidelines.英国疟疾治疗指南。
J Infect. 2007 Feb;54(2):111-21. doi: 10.1016/j.jinf.2006.12.003. Epub 2007 Jan 9.
10
Efficacy of Chloroquine for the Treatment of Vivax malaria in Northwest Ethiopia.氯喹治疗埃塞俄比亚西北部间日疟的疗效
PLoS One. 2016 Aug 31;11(8):e0161483. doi: 10.1371/journal.pone.0161483. eCollection 2016.

引用本文的文献

1
Efficacy of Focal Primaquine Mass Administration for Eliminating Malaria in Northern Myanmar: A Cluster-Randomized Trial.在缅甸北部进行的群体随机试验:采用伯氨喹局部群体给药法消除疟疾的疗效
Open Forum Infect Dis. 2025 Aug 5;12(8):ofaf465. doi: 10.1093/ofid/ofaf465. eCollection 2025 Aug.
2
Breaking the cycle of malaria treatment failure.打破疟疾治疗失败的循环。
Front Epidemiol. 2022 Dec 14;2:1041896. doi: 10.3389/fepid.2022.1041896. eCollection 2022.
3
Antimalarial mass drug administration in large populations and the evolution of drug resistance.
在大量人群中进行抗疟大规模药物给药与耐药性的演变。
PLOS Glob Public Health. 2023 Jul 26;3(7):e0002200. doi: 10.1371/journal.pgph.0002200. eCollection 2023.
4
The relative impact of interventions on sympatric Plasmodium vivax and Plasmodium falciparum malaria: A systematic review.干预措施对同域分布的间日疟原虫和恶性疟原虫疟疾的相对影响:系统评价。
PLoS Negl Trop Dis. 2022 Jun 29;16(6):e0010541. doi: 10.1371/journal.pntd.0010541. eCollection 2022 Jun.
5
Malaria chemoprevention and drug resistance: a review of the literature and policy implications.疟疾化学预防和药物耐药性:文献综述及政策影响。
Malar J. 2022 Mar 24;21(1):104. doi: 10.1186/s12936-022-04115-8.
6
Is it time for Africa to adopt primaquine in the era of malaria control and elimination?在疟疾控制与消除的时代,非洲是时候采用伯氨喹了吗?
Trop Med Health. 2022 Feb 25;50(1):17. doi: 10.1186/s41182-022-00408-5.
7
Mass drug administration for malaria.大规模药物治疗疟疾。
Cochrane Database Syst Rev. 2021 Sep 29;9(9):CD008846. doi: 10.1002/14651858.CD008846.pub3.
8
Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.迈向消除间日疟原虫疟疾:实施根治措施。
PLoS Med. 2021 Apr 23;18(4):e1003494. doi: 10.1371/journal.pmed.1003494. eCollection 2021 Apr.
9
The prevention and treatment of Plasmodium vivax malaria.疟原虫 vivax 疟疾的预防和治疗。
PLoS Med. 2021 Apr 23;18(4):e1003561. doi: 10.1371/journal.pmed.1003561. eCollection 2021 Apr.
10
Tafenoquine: a toxicity overview.他非喹:毒性概述。
Expert Opin Drug Saf. 2021 Mar;20(3):349-362. doi: 10.1080/14740338.2021.1859476. Epub 2021 Jan 4.